All treatments
Treatment
Dexamethason CF 20 mg/ml clinical trials
2 indexed studies · 0 currently recruiting
- Ongoing, recruitingTherapeutic confirmatory (Phase III)
A Phase 3, Multicenter, Randomized, Open-label Study to Compare the Efficacy and Safety of bb2121 Versus Standard Regimens in Subjects with Relapsed and Refractory Multiple Myeloma (RRMM) (KarMMa-3)
This study looks at a new treatment, idecabtagene vicleucel (bb2121), for multiple myeloma that has come back or not responded to previous treatments. It compares this new treatment to standard options to see if it works better and is safe for patients aged 18 and over.
Germany · Spain · Italy - Ongoing, recruitingPhase III and phase IV (Integrated)
Comparison of different doses of perineural dexmedetomidine as adjuvans to ropivacaine 0,67% for interscalene plexus block in association with 10 mg intravenous dexamethasone: a single center, double blinded, randomised controlled trial.
This study looks at how different doses of a medicine called dexmedetomidine, when added to a local anaesthetic for shoulder surgery, affect pain relief. It aims to find out the best way to keep you comfortable after your operation.
For: Patients scheduled for shoulder operationsBelgium